{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:38:07Z","timestamp":1790483887691,"version":"4.1.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260201"],"award-info":[{"award-number":["82260201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR5RA917"],"award-info":[{"award-number":["22JR5RA917"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016321","name":"First Clinical Medical School, Lanzhou University","doi-asserted-by":"publisher","award":["ldyyyn2018-22"],"award-info":[{"award-number":["ldyyyn2018-22"]}],"id":[{"id":"10.13039\/501100016321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Industry Management Project of Gansu Province","award":["GSWSKY-2019-93"],"award-info":[{"award-number":["GSWSKY-2019-93"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Bone morphogenetic proteins (BMPs), belonging to the transforming growth factor \u03b2 (TGF-\u03b2) family, are multifunctional growth factors predominantly distributed in human bone tissue. Some studies also have revealed that BMPs are widely expressed in ocular tissues. Over the past two decades, research on the therapeutic application of BMPs has yielded significant advancements not only in the treatment of skeletal, cardiac, renal and neurological diseases but also in ocular conditions. Both in vivo and in vitro experiments have demonstrated the significant therapeutic efficacy of BMPs in various ocular disorders, including myopia, corneal opacity, cataract, uveal melanoma, retinal detachment and other eye diseases. Studies have further identified that BMPs exert their actions through mechanisms closely associated with the canonical Smad pathway. Compared to traditional therapeutic drugs, BMPs exhibit some advantages, including low toxicity, minimal side effects, amongst others. However, numerous unresolved issues persist during in vivo and in vitro experiments. The objective of this review is to explore the advancements in the application of BMPs for the treatment of ocular diseases in animal models or in vitro experiments, and to provide some insights into the challenges that need to be addressed for the translation of BMP-based therapies into clinical practice.<\/jats:p>","DOI":"10.1186\/s40662-025-00445-1","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T02:34:24Z","timestamp":1753238064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bone morphogenetic proteins (BMPs) at the forefront of ocular diseases and therapeutics"],"prefix":"10.1186","volume":"12","author":[{"given":"Yurong","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-6494","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"4885","key":"445_CR1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1126\/science.3201241","volume":"242","author":"JM Wozney","year":"1988","unstructured":"Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242(4885):1528\u201334.","journal-title":"Science"},{"issue":"4","key":"445_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0955-2235(89)90015-X","volume":"1","author":"JM Wozney","year":"1989","unstructured":"Wozney JM. Bone morphogenetic proteins. Prog Growth Factor Res. 1989;1(4):267\u201380.","journal-title":"Prog Growth Factor Res"},{"issue":"4","key":"445_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cellsig.2010.10.003","volume":"23","author":"B Bragdon","year":"2011","unstructured":"Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. Bone morphogenetic proteins: a critical review. Cell Signal. 2011;23(4):609\u201320.","journal-title":"Cell Signal"},{"issue":"Suppl 1","key":"445_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-0722.1998.tb02170.x","volume":"106","author":"JM Wozney","year":"1998","unstructured":"Wozney JM. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci. 1998;106(Suppl 1):160\u20136.","journal-title":"Eur J Oral Sci"},{"issue":"16 Suppl 1","key":"445_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007632-200208151-00002","volume":"27","author":"JM Wozney","year":"2002","unstructured":"Wozney JM. Overview of bone morphogenetic proteins. Spine (Phila Pa 1976). 2002;27(16 Suppl 1):S2-8.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"4","key":"445_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08977190412331279890","volume":"22","author":"D Chen","year":"2004","unstructured":"Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22(4):233\u201341.","journal-title":"Growth Factors"},{"issue":"3","key":"445_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cytogfr.2005.04.003","volume":"16","author":"AH Reddi","year":"2005","unstructured":"Reddi AH. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev. 2005;16(3):249\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"445_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.bbrc.2007.08.045","volume":"362","author":"YT Xiao","year":"2007","unstructured":"Xiao YT, Xiang LX, Shao JZ. Bone morphogenetic protein. Biochem Biophys Res Commun. 2007;362(3):550\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"445_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0959-437X(96)80064-5","volume":"6","author":"BL Hogan","year":"1996","unstructured":"Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6(4):432\u20138.","journal-title":"Curr Opin Genet Dev"},{"issue":"12","key":"445_CR10","first-page":"927","volume":"101","author":"H Yamashita","year":"1997","unstructured":"Yamashita H, Tobari I, Sawa M, Hori S, Miyazono K, Heldin CH, et al. Functions of the transforming growth factor-beta superfamily in eyes. Nippon Ganka Gakkai Zasshi. 1997;101(12):927\u201347.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"8","key":"445_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3181\/0510-MR-345","volume":"232","author":"RJ Wordinger","year":"2007","unstructured":"Wordinger RJ, Clark AF. Bone morphogenetic proteins and their receptors in the eye. Exp Biol Med (Maywood). 2007;232(8):979\u201392.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2\u20133","key":"445_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jop.2013.0220","volume":"30","author":"RJ Wordinger","year":"2014","unstructured":"Wordinger RJ, Sharma T, Clark AF. The role of TGF-\u03b22 and bone morphogenetic proteins in the trabecular meshwork and glaucoma. J Ocul Pharmacol Ther. 2014;30(2\u20133):154\u201362.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"445_CR13","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.4081\/ejh.2017.2797","volume":"61","author":"Y Maruyama-Koide","year":"2017","unstructured":"Maruyama-Koide Y, Mikawa S, Sasaki T, Sato K. Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye. Eur J Histochem. 2017;61(3):2797.","journal-title":"Eur J Histochem"},{"issue":"2","key":"445_CR14","first-page":"296","volume":"40","author":"L You","year":"1999","unstructured":"You L, Kruse FE, Pohl J, V\u00f6lcker HE. Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Invest Ophthalmol Vis Sci. 1999;40(2):296\u2013311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"445_CR15","first-page":"241","volume":"8","author":"RJ Wordinger","year":"2002","unstructured":"Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis. 2002;8:241\u201350.","journal-title":"Mol Vis"},{"issue":"2","key":"445_CR16","first-page":"592","volume":"41","author":"JR Mathura Jr","year":"2000","unstructured":"Mathura JR Jr, Jafari N, Chang JT, Hackett SF, Wahlin KJ, Della NG, et al. Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium. Invest Ophthalmol Vis Sci. 2000;41(2):592\u2013600.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"445_CR17","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/j.1460-9568.2004.03681.x","volume":"20","author":"W Shen","year":"2004","unstructured":"Shen W, Finnegan S, Lein P, Sullivan S, Slaughter M, Higgins D. Bone morphogenetic proteins regulate ionotropic glutamate receptors in human retina. Eur J Neurosci. 2004;20(8):2031\u20137.","journal-title":"Eur J Neurosci"},{"issue":"10","key":"445_CR18","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3390\/cells10102604","volume":"10","author":"DY Shu","year":"2021","unstructured":"Shu DY, Lovicu FJ. Insights into bone morphogenetic protein-(BMP-) signaling in ocular lens biology and pathology. Cells. 2021;10(10):2604.","journal-title":"Cells"},{"issue":"2","key":"445_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1387\/ijdb.062185jh","volume":"51","author":"JC Hocking","year":"2007","unstructured":"Hocking JC, McFarlane S. Expression of Bmp ligands and receptors in the developing Xenopus retina. Int J Dev Biol. 2007;51(2):161\u20135.","journal-title":"Int J Dev Biol"},{"key":"445_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-213X-11-54","volume":"11","author":"RC Day","year":"2011","unstructured":"Day RC, Beck CW. Transdifferentiation from cornea to lens in Xenopus laevis depends on BMP signalling and involves upregulation of Wnt signalling. BMC Dev Biol. 2011;11:54.","journal-title":"BMC Dev Biol"},{"key":"445_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05216","volume":"4","author":"S Heermann","year":"2015","unstructured":"Heermann S, Sch\u00fctz L, Lemke S, Krieglstein K, Wittbrodt J. Eye morphogenesis driven by epithelial flow into the optic cup facilitated by modulation of bone morphogenetic protein. Elife. 2015;4:e05216.","journal-title":"Elife"},{"issue":"2","key":"445_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ydbio.2015.09.009","volume":"407","author":"J Huang","year":"2015","unstructured":"Huang J, Liu Y, Filas B, Gunhaga L, Beebe DC. Negative and positive auto-regulation of BMP expression in early eye development. Dev Biol. 2015;407(2):256\u201364.","journal-title":"Dev Biol"},{"issue":"14","key":"445_CR23","doi-asserted-by":"publisher","first-page":"dev200633","DOI":"10.1242\/dev.200633","volume":"149","author":"S Mai","year":"2022","unstructured":"Mai S, Zhu X, Wan EYC, Wu S, Yonathan JN, Wang J, et al. Postnatal eye size in mice is controlled by SREBP2-mediated transcriptional repression of Lrp2 and Bmp2. Development. 2022;149(14):dev200633.","journal-title":"Development"},{"issue":"19","key":"445_CR24","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1242\/dev.129.19.4435","volume":"129","author":"S Zhao","year":"2002","unstructured":"Zhao S, Chen Q, Hung FC, Overbeek PA. BMP signaling is required for development of the ciliary body. Development. 2002;129(19):4435\u201342.","journal-title":"Development"},{"issue":"12","key":"445_CR25","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1093\/emboj\/cdg291","volume":"22","author":"AA Sharov","year":"2003","unstructured":"Sharov AA, Weiner L, Sharova TY, Siebenhaar F, Atoyan R, Reginato AM, et al. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J. 2003;22(12):2992\u20133003.","journal-title":"EMBO J"},{"issue":"1","key":"445_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ydbio.2003.11.013","volume":"267","author":"T Kondo","year":"2004","unstructured":"Kondo T, Raff MC. A role for Noggin in the development of oligodendrocyte precursor cells. Dev Biol. 2004;267(1):242\u201351.","journal-title":"Dev Biol"},{"issue":"4\u20136","key":"445_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1387\/ijdb.150402am","volume":"60","author":"A Messina","year":"2016","unstructured":"Messina A, Bridi S, Bozza A, Bozzi Y, Baudet ML, Casarosa S. Noggin 1 overexpression in retinal progenitors affects bipolar cell generation. Int J Dev Biol. 2016;60(4\u20136):151\u20137.","journal-title":"Int J Dev Biol"},{"issue":"1","key":"445_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith III EL, Zhou X, et al. Myopia. Nat Rev Dis Primers. 2020;6(1):99.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"445_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41433-021-01805-6","volume":"36","author":"X Han","year":"2022","unstructured":"Han X, Liu C, Chen Y, He M. Myopia prediction: a systematic review. Eye (Lond). 2022;36(5):921\u20139.","journal-title":"Eye (Lond)"},{"issue":"6","key":"445_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.64.6.2","volume":"64","author":"MA Bullimore","year":"2023","unstructured":"Bullimore MA, Lee SS, Schmid KL, Rozema JJ, Leveziel N, Mallen EAH, et al. IMI-Onset and progression of myopia in young adults. Invest Ophthalmol Vis Sci. 2023;64(6):2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"445_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.preteyeres.2018.12.001","volume":"70","author":"K Ohno-Matsui","year":"2019","unstructured":"Ohno-Matsui K, Jonas JB. Posterior staphyloma in pathologic myopia. Prog Retin Eye Res. 2019;70:99\u2013109.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"445_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.18240\/ijo.2022.03.21","volume":"15","author":"Q Yu","year":"2022","unstructured":"Yu Q, Zhou JB. Scleral remodeling in myopia development. Int J Ophthalmol. 2022;15(3):510\u20134.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"445_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","volume":"78","author":"PG Watson","year":"2004","unstructured":"Watson PG, Young RD. Scleral structure, organisation and disease. A review. Exp Eye Res. 2004;78(3):609\u201323.","journal-title":"Exp Eye Res"},{"issue":"19","key":"445_CR34","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1074\/jbc.M300970200","volume":"278","author":"A Gentle","year":"2003","unstructured":"Gentle A, Liu Y, Martin JE, Conti GL, McBrien NA. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J Biol Chem. 2003;278(19):16587\u201394.","journal-title":"J Biol Chem"},{"issue":"1","key":"445_CR35","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1097\/OPX.0b013e3181940669","volume":"86","author":"NA McBrien","year":"2009","unstructured":"McBrien NA, Jobling AI, Gentle A. Biomechanics of the sclera in myopia: extracellular and cellular factors. Optom Vis Sci. 2009;86(1):E23-30.","journal-title":"Optom Vis Sci"},{"key":"445_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajo.2016.06.033","volume":"169","author":"K Shinohara","year":"2016","unstructured":"Shinohara K, Moriyama M, Shimada N, Yoshida T, Ohno-Matsui K. Characteristics of peripapillary staphylomas associated with high myopia determined by swept-source optical coherence tomography. Am J Ophthalmol. 2016;169:138\u201344.","journal-title":"Am J Ophthalmol"},{"key":"445_CR37","first-page":"647","volume":"17","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhao G, Xing S, Zhang L, Yang X. Role of bone morphogenetic proteins in form-deprivation myopia sclera. Mol Vis. 2011;17:647\u201357.","journal-title":"Mol Vis"},{"issue":"5","key":"445_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125219","volume":"10","author":"H Li","year":"2015","unstructured":"Li H, Cui D, Zhao F, Huo L, Hu J, Zeng J. BMP-2 is involved in scleral remodeling in myopia development. PLoS One. 2015;10(5):e0125219.","journal-title":"PLoS One"},{"issue":"1","key":"445_CR39","first-page":"39","volume":"8","author":"Q Wang","year":"2015","unstructured":"Wang Q, Xue ML, Zhao GQ, Liu MG, Ma YN, Ma Y. Form-deprivation myopia induces decreased expression of bone morphogenetic protein-2, 5 in guinea pig sclera. Int J Ophthalmol. 2015;8(1):39\u201345.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"445_CR40","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3892\/mmr.2016.4843","volume":"13","author":"H Li","year":"2016","unstructured":"Li H, Wu J, Cui D, Zeng J. Retinal and choroidal expression of BMP-2 in lens-induced myopia and recovery from myopia in guinea pigs. Mol Med Rep. 2016;13(3):2671\u20136.","journal-title":"Mol Med Rep"},{"key":"445_CR41","first-page":"2373","volume":"14","author":"J Hu","year":"2008","unstructured":"Hu J, Cui D, Yang X, Wang S, Hu S, Li C, et al. Bone morphogenetic protein-2: a potential regulator in scleral remodeling. Mol Vis. 2008;14:2373\u201380.","journal-title":"Mol Vis"},{"issue":"11","key":"445_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003709","volume":"3","author":"Y Seko","year":"2008","unstructured":"Seko Y, Azuma N, Takahashi Y, Makino H, Morito T, Muneta T, et al. Human sclera maintains common characteristics with cartilage throughout evolution. PLoS One. 2008;3(11):e3709.","journal-title":"PLoS One"},{"issue":"6","key":"445_CR43","first-page":"1249","volume":"41","author":"D Troilo","year":"2000","unstructured":"Troilo D, Nickla DL, Wildsoet CF. Choroidal thickness changes during altered eye growth and refractive state in a primate. Invest Ophthalmol Vis Sci. 2000;41(6):1249\u201358.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"445_CR44","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/biom13091373","volume":"13","author":"S Goto","year":"2023","unstructured":"Goto S, Zhang Y, Vyas SA, Zhu Q, Wildsoet CF. Changes in expression in BMP2 and two closely related genes in guinea pig retinal pigment epithelium during induction and recovery from myopia. Biomolecules. 2023;13(9):1373.","journal-title":"Biomolecules"},{"issue":"10","key":"445_CR45","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.0906-6705.2004.00206.x","volume":"13","author":"RF O\u2019Shaughnessy","year":"2004","unstructured":"O\u2019Shaughnessy RF, Christiano AM, Jahoda CA. The role of BMP signalling in the control of ID3 expression in the hair follicle. Exp Dermatol. 2004;13(10):621\u20139.","journal-title":"Exp Dermatol"},{"issue":"10","key":"445_CR46","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2023.0052","volume":"329","author":"C Kraus","year":"2023","unstructured":"Kraus C, Kuwera E. What is strabismus? JAMA. 2023;329(10):856.","journal-title":"JAMA"},{"issue":"2","key":"445_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaapos.2014.03.001","volume":"18","author":"D Stager Jr","year":"2014","unstructured":"Stager D Jr. Adult strabismus: it\u2019s never too late. J AAPOS. 2014;18(2):103\u20134.","journal-title":"J AAPOS"},{"issue":"1","key":"445_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaapos.2008.06.001","volume":"13","author":"NS Ekdawi","year":"2009","unstructured":"Ekdawi NS, Nusz KJ, Diehl NN, Mohney BG. Postoperative outcomes in children with intermittent exotropia from a population-based cohort. J AAPOS. 2009;13(1):4\u20137.","journal-title":"J AAPOS"},{"issue":"7","key":"445_CR49","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1167\/iovs.10-6878","volume":"52","author":"BC Anderson","year":"2011","unstructured":"Anderson BC, Daniel ML, Kendall JD, Christiansen SP, McLoon LK. Sustained release of bone morphogenetic protein-4 in adult rabbit extraocular muscle results in decreased force and muscle size: potential for strabismus treatment. Invest Ophthalmol Vis Sci. 2011;52(7):4021\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"445_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0008-6363(97)00011-4","volume":"34","author":"SJ Gilbert","year":"1997","unstructured":"Gilbert SJ, Wotton PR, Tarlton JF, Duance VC, Bailey AJ. Increased expression of promatrix metalloproteinase-9 and neutrophil elastase in canine dilated cardiomyopathy. Cardiovasc Res. 1997;34(2):377\u201383.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"445_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1388-9842(99)00048-3","volume":"1","author":"P Rouet-Benzineb","year":"1999","unstructured":"Rouet-Benzineb P, Buhler JM, Dreyfus P, Delcourt A, Dorent R, Perennec J, et al. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail. 1999;1(4):337\u201352.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"445_CR52","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1111\/aos.14217","volume":"98","author":"YP Lee","year":"2020","unstructured":"Lee YP, Choi DG. MMPs, TIMPs and BMP-4 in medial rectus muscle obtained from intermittent exotropia patients and their clinical correlations. Acta Ophthalmol. 2020;98(1):e107\u201312.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"445_CR53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","volume":"37","author":"DW DelMonte","year":"2011","unstructured":"DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37(3):588\u201398.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"445_CR54","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1167\/iovs.17-23308","volume":"59","author":"S Gupta","year":"2018","unstructured":"Gupta S, Fink MK, Ghosh A, Tripathi R, Sinha PR, Sharma A, et al. Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo. Invest Ophthalmol Vis Sci. 2018;59(2):1045\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"445_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108272","volume":"201","author":"SE Wilson","year":"2020","unstructured":"Wilson SE. Corneal myofibroblasts and fibrosis. Exp Eye Res. 2020;201:108272.","journal-title":"Exp Eye Res"},{"key":"445_CR56","doi-asserted-by":"publisher","first-page":"20841","DOI":"10.1038\/srep20841","volume":"6","author":"RR Lim","year":"2016","unstructured":"Lim RR, Tan A, Liu YC, Barathi VA, Mohan RR, Mehta JS, et al. ITF2357 transactivates Id3 and regulate TGF\u03b2\/BMP7 signaling pathways to attenuate corneal fibrosis. Sci Rep. 2016;6:20841.","journal-title":"Sci Rep"},{"key":"445_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115317","volume":"209","author":"L Trujillo Cubillo","year":"2024","unstructured":"Trujillo Cubillo L, Gurdal M, Zeugolis DI. Corneal fibrosis: from in vitro models to current and upcoming drug and gene medicines. Adv Drug Deliv Rev. 2024;209:115317.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"445_CR58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/labinvest.3700247","volume":"85","author":"S Saika","year":"2005","unstructured":"Saika S, Ikeda K, Yamanaka O, Flanders KC, Nakajima Y, Miyamoto T, et al. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest. 2005;85(4):474\u201386.","journal-title":"Lab Invest"},{"issue":"3","key":"445_CR59","first-page":"329","volume":"10","author":"JK Chung","year":"2017","unstructured":"Chung JK, Park SA, Hwang HS, Kim KS, Cho YJ, You YS, et al. Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis. Int J Ophthalmol. 2017;10(3):329\u201335.","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"445_CR60","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003;9(7):964\u20138.","journal-title":"Nat Med"},{"issue":"6","key":"445_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066434","volume":"8","author":"A Tandon","year":"2013","unstructured":"Tandon A, Sharma A, Rodier JT, Klibanov AM, Rieger FG, Mohan RR. BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo. PLoS One. 2013;8(6):e66434.","journal-title":"PLoS One"},{"issue":"2","key":"445_CR62","first-page":"833","volume":"21","author":"Y Song","year":"2020","unstructured":"Song Y, Lv S, Wang F, Liu X, Cheng J, Liu S, et al. Overexpression of BMP-7 reverses TGF-\u03b21-induced epithelial-mesenchymal transition by attenuating the Wnt3\/\u03b2-catenin and TGF-\u03b21\/Smad2\/3 signaling pathways in HK-2 cells. Mol Med Rep. 2020;21(2):833\u201341.","journal-title":"Mol Med Rep"},{"issue":"5","key":"445_CR63","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"4","key":"445_CR64","doi-asserted-by":"publisher","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","volume":"297","author":"M Pang","year":"2009","unstructured":"Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol. 2009;297(4):F996-1005.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5\u20136","key":"445_CR65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2119\/molmed.2011.00022","volume":"17","author":"TA McKinsey","year":"2011","unstructured":"McKinsey TA. Targeting inflammation in heart failure with histone deacetylase inhibitors. Mol Med. 2011;17(5\u20136):434\u201341.","journal-title":"Mol Med"},{"issue":"5","key":"445_CR66","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1183\/09031936.00095113","volume":"43","author":"YY Sanders","year":"2014","unstructured":"Sanders YY, Hagood JS, Liu H, Zhang W, Ambalavanan N, Thannickal VJ. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. Eur Respir J. 2014;43(5):1448\u201358.","journal-title":"Eur Respir J"},{"issue":"3","key":"445_CR67","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/bjophthalmol-2018-312630","volume":"103","author":"MA Diamond","year":"2019","unstructured":"Diamond MA, Chan SWS, Zhou X, Glinka Y, Girard E, Yucel Y, et al. Lymphatic vessels identified in failed corneal transplants with neovascularisation. Br J Ophthalmol. 2019;103(3):421\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"445_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2012.09.018","volume":"372","author":"D Ribatti","year":"2012","unstructured":"Ribatti D, Crivellato E. \u201cSprouting angiogenesis\u201d, a reappraisal. Dev Biol. 2012;372(2):157\u201365.","journal-title":"Dev Biol"},{"key":"445_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109680","volume":"237","author":"W Nan","year":"2023","unstructured":"Nan W, He Y, Shen S, Wu M, Wang S, Zhang Y. BMP4 inhibits corneal neovascularization by interfering with tip cells in angiogenesis. Exp Eye Res. 2023;237:109680.","journal-title":"Exp Eye Res"},{"key":"445_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106902","volume":"88","author":"K Yuan","year":"2020","unstructured":"Yuan K, Zheng J, Huang X, Zhang Y, Han Y, Hu R, et al. Neutrophil extracellular traps promote corneal neovascularization-induced by alkali burn. Int Immunopharmacol. 2020;88:106902.","journal-title":"Int Immunopharmacol"},{"issue":"Pt A","key":"445_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113023","volume":"142","author":"S Shen","year":"2024","unstructured":"Shen S, Nan W, Zhang W, Wu H, Zhang Y. Bone morphogenetic protein 4 inhibits corneal neovascularization by blocking NETs-induced disruption to corneal epithelial barrier. Int Immunopharmacol. 2024;142(Pt A):113023.","journal-title":"Int Immunopharmacol"},{"key":"445_CR72","first-page":"264","volume":"104","author":"DT Azar","year":"2006","unstructured":"Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264\u2013302.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"9","key":"445_CR73","first-page":"2514","volume":"41","author":"W Philipp","year":"2000","unstructured":"Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41(9):2514\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"445_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108769","volume":"212","author":"H Hu","year":"2021","unstructured":"Hu H, Wang S, He Y, Shen S, Yao B, Xu D, et al. The role of bone morphogenetic protein 4 in corneal injury repair. Exp Eye Res. 2021;212:108769.","journal-title":"Exp Eye Res"},{"issue":"3","key":"445_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/stem.2750","volume":"36","author":"TA Kamarudin","year":"2018","unstructured":"Kamarudin TA, Bojic S, Collin J, Yu M, Alharthi S, Buck H, et al. Differences in the activity of endogenous bone morphogenetic protein signaling impact on the ability of induced pluripotent stem cells to differentiate to corneal epithelial-like cells. Stem Cells. 2018;36(3):337\u201348.","journal-title":"Stem Cells"},{"issue":"10","key":"445_CR76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1167\/iovs.61.10.46","volume":"61","author":"A Tiwari","year":"2020","unstructured":"Tiwari A, Swamynathan S, Campbell G, Jhanji V, Swamynathan SK. BMP6 regulates corneal epithelial cell stratification by coordinating their proliferation and differentiation and is upregulated in pterygium. Invest Ophthalmol Vis Sci. 2020;61(10):46.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"445_CR77","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/cimb43030147","volume":"43","author":"HS Lee","year":"2021","unstructured":"Lee HS, Mok J, Joo CK. Bone morphogenetic protein 4 (BMP4) enhances the differentiation of human induced pluripotent stem cells into limbal progenitor cells. Curr Issues Mol Biol. 2021;43(3):2124\u201334.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"445_CR78","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3390\/ijms23063078","volume":"23","author":"HT Nguyen","year":"2022","unstructured":"Nguyen HT, Theerakittayakorn K, Somredngan S, Ngernsoungnern A, Ngernsoungnern P, Sritangos P, et al. Signaling pathways impact on induction of corneal epithelial-like cells derived from human Wharton\u2019s Jelly mesenchymal stem cells. Int J Mol Sci. 2022;23(6):3078.","journal-title":"Int J Mol Sci"},{"key":"445_CR79","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","volume":"11","author":"BA Krantz","year":"2017","unstructured":"Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279\u201389.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"445_CR80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"445_CR81","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1167\/iovs.07-0505","volume":"48","author":"I Notting","year":"2007","unstructured":"Notting I, Buijs J, Mintardjo R, van der Horst G, Vukicevic S, Lowik C, et al. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo. Invest Ophthalmol Vis Sci. 2007;48(11):4882\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"445_CR82","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ijc.23139","volume":"122","author":"C Busch","year":"2008","unstructured":"Busch C, Drews U, Eisele SR, Garbe C, Oppitz M. Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo. Int J Cancer. 2008;122(3):526\u201333.","journal-title":"Int J Cancer"},{"issue":"11","key":"445_CR83","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41374-021-00661-y","volume":"101","author":"J Gao","year":"2021","unstructured":"Gao J, Muroya R, Huang F, Nagata K, Shin M, Nagano R, et al. Bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1\/5 signaling pathway. Lab Invest. 2021;101(11):1475\u201383.","journal-title":"Lab Invest"},{"issue":"21","key":"445_CR84","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1016\/j.cell.2024.08.013","volume":"187","author":"Y Chhabra","year":"2024","unstructured":"Chhabra Y, Fane ME, Pramod S, H\u00fcser L, Zabransky DJ, Wang V, et al. Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. Cell. 2024;187(21):6016-34.e25.","journal-title":"Cell"},{"issue":"3","key":"445_CR85","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","volume":"105","author":"JM Kang","year":"2021","unstructured":"Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493\u2013510.","journal-title":"Med Clin North Am"},{"issue":"10414","key":"445_CR86","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788\u2013801.","journal-title":"Lancet"},{"key":"445_CR87","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9462","volume":"8","author":"DW Zhang","year":"2020","unstructured":"Zhang DW, Zhang S, Wu J. Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM. PeerJ. 2020;8:e9462.","journal-title":"PeerJ"},{"issue":"2","key":"445_CR88","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ceo.14027","volume":"50","author":"KE Keller","year":"2022","unstructured":"Keller KE, Peters DM. Pathogenesis of glaucoma: extracellular matrix dysfunction in the trabecular meshwork-a review. Clin Exp Ophthalmol. 2022;50(2):163\u201382.","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"445_CR89","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1167\/iovs.06-0296","volume":"48","author":"RJ Wordinger","year":"2007","unstructured":"Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, Zode GS, et al. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48(3):1191\u2013200.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"445_CR90","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/glia.20803","volume":"57","author":"GS Zode","year":"2009","unstructured":"Zode GS, Clark AF, Wordinger RJ. Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation. Glia. 2009;57(7):755\u201366.","journal-title":"Glia"},{"issue":"6","key":"445_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038690","volume":"7","author":"Y Ueki","year":"2012","unstructured":"Ueki Y, Reh TA. Activation of BMP-Smad1\/5\/8 signaling promotes survival of retinal ganglion cells after damage in vivo. PLoS One. 2012;7(6):e38690.","journal-title":"PLoS One"},{"issue":"5","key":"445_CR92","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1167\/iovs.18-26449","volume":"60","author":"A Thompson","year":"2019","unstructured":"Thompson A, Berry M, Logan A, Ahmed Z. Activation of the BMP4\/Smad1 pathway promotes retinal ganglion cell survival and axon regeneration. Invest Ophthalmol Vis Sci. 2019;60(5):1748\u201359.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"445_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108728","volume":"210","author":"D Liu","year":"2021","unstructured":"Liu D, Deng Q, Lei X, Lu W, Zhao Q, Shen Y. Overexpression of BMP4 protects retinal ganglion cells in a mouse model of experimental glaucoma. Exp Eye Res. 2021;210:108728.","journal-title":"Exp Eye Res"},{"issue":"10094","key":"445_CR94","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"YC Liu","year":"2017","unstructured":"Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390(10094):600\u201312.","journal-title":"Lancet"},{"issue":"1\u20132","key":"445_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000084508","volume":"179","author":"RU de Iongh","year":"2005","unstructured":"de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 2005;179(1\u20132):43\u201355.","journal-title":"Cells Tissues Organs"},{"issue":"13","key":"445_CR96","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/jcm10132847","volume":"10","author":"J Konopi\u0144ska","year":"2021","unstructured":"Konopi\u0144ska J, M\u0142ynarczyk M, Dmuchowska DA, Obuchowska I. Posterior capsule opacification: a review of experimental studies. J Clin Med. 2021;10(13):2847.","journal-title":"J Clin Med"},{"issue":"2","key":"445_CR97","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1167\/iovs.16-20611","volume":"58","author":"DY Shu","year":"2017","unstructured":"Shu DY, Wojciechowski MC, Lovicu FJ. Bone morphogenetic protein-7 suppresses TGF\u03b22-induced epithelial-mesenchymal transition in the lens: implications for cataract prevention. Invest Ophthalmol Vis Sci. 2017;58(2):781\u201396.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"445_CR98","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/biof.1177","volume":"40","author":"A Oryan","year":"2014","unstructured":"Oryan A, Alidadi S, Moshiri A, Bigham-Sadegh A. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations. BioFactors. 2014;40(5):459\u201381.","journal-title":"BioFactors"},{"key":"445_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108546","volume":"206","author":"DY Shu","year":"2021","unstructured":"Shu DY, Ng K, Wishart TFL, Chui J, Lundmark M, Flokis M, et al. Contrasting roles for BMP-4 and ventromorphins (BMP agonists) in TGF\u03b2-induced lens EMT. Exp Eye Res. 2021;206:108546.","journal-title":"Exp Eye Res"},{"issue":"4","key":"445_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.64.4.12","volume":"64","author":"F Jiang","year":"2023","unstructured":"Jiang F, Qin Y, Yang Y, Li Z, Cui B, Ju R, et al. BMP-4 and BMP-7 inhibit EMT in a model of anterior subcapsular cataract in part by regulating the notch signaling pathway. Invest Ophthalmol Vis Sci. 2023;64(4):12.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"445_CR101","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/glia.22477","volume":"61","author":"A Reichenbach","year":"2013","unstructured":"Reichenbach A, Bringmann A. New functions of M\u00fcller cells. Glia. 2013;61(5):651\u201378.","journal-title":"Glia"},{"issue":"4","key":"445_CR102","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.mcn.2004.08.007","volume":"27","author":"AJ Fischer","year":"2004","unstructured":"Fischer AJ, Schmidt M, Omar G, Reh TA. BMP4 and CNTF are neuroprotective and suppress damage-induced proliferation of M\u00fcller glia in the retina. Mol Cell Neurosci. 2004;27(4):531\u201342.","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"445_CR103","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/glia.22472","volume":"61","author":"Y Ueki","year":"2013","unstructured":"Ueki Y, Reh TA. EGF stimulates M\u00fcller glial proliferation via a BMP-dependent mechanism. Glia. 2013;61(5):778\u201389.","journal-title":"Glia"},{"issue":"1","key":"445_CR104","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12964-023-01223-z","volume":"21","author":"VV Byroju","year":"2023","unstructured":"Byroju VV, Nadukkandy AS, Cordani M, Kumar LD. Retinoblastoma: present scenario and future challenges. Cell Commun Signal. 2023;21(1):226.","journal-title":"Cell Commun Signal"},{"issue":"17","key":"445_CR105","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/sj.onc.1207386","volume":"23","author":"TB Ro","year":"2004","unstructured":"Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene. 2004;23(17):3024\u201332.","journal-title":"Oncogene"},{"issue":"7","key":"445_CR106","doi-asserted-by":"publisher","first-page":"700","DOI":"10.7150\/ijbs.6.700","volume":"6","author":"M Haubold","year":"2010","unstructured":"Haubold M, Weise A, Stephan H, D\u00fcnker N. Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. Int J Biol Sci. 2010;6(7):700\u201315.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"445_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131467","volume":"10","author":"P M\u00fcller","year":"2015","unstructured":"M\u00fcller P, Doliva R, Busch M, Philippeit C, Stephan H, D\u00fcnker N. Additive effects of retinoic acid (RA) and bone morphogenetic protein 4 (BMP-4) apoptosis signaling in retinoblastoma cell lines. PLoS One. 2015;10(7):e0131467.","journal-title":"PLoS One"},{"issue":"6","key":"445_CR108","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/ijms19061816","volume":"19","author":"W Wang","year":"2018","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"445_CR109","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/biom11040593","volume":"11","author":"K Elmasry","year":"2021","unstructured":"Elmasry K, Habib S, Moustafa M, Al-Shabrawey M. Bone morphogenetic proteins and diabetic retinopathy. Biomolecules. 2021;11(4):593.","journal-title":"Biomolecules"},{"key":"445_CR110","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.exer.2014.05.012","volume":"125","author":"KA Hussein","year":"2014","unstructured":"Hussein KA, Choksi K, Akeel S, Ahmad S, Megyerdi S, El-Sherbiny M, et al. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Exp Eye Res. 2014;125:79\u201388.","journal-title":"Exp Eye Res"},{"issue":"9","key":"445_CR111","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/cells12091279","volume":"12","author":"NHE Darwish","year":"2023","unstructured":"Darwish NHE, Hussein KA, Elmasry K, Ibrahim AS, Humble J, Moustafa M, et al. Bone morphogenetic protein-4 impairs retinal endothelial cell barrier, a potential role in diabetic retinopathy. Cells. 2023;12(9):1279.","journal-title":"Cells"},{"issue":"2","key":"445_CR112","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00109-020-01995-8","volume":"99","author":"L Dong","year":"2021","unstructured":"Dong L, Zhang Z, Liu X, Wang Q, Hong Y, Li X, et al. RNA sequencing reveals BMP4 as a basis for the dual-target treatment of diabetic retinopathy. J Mol Med (Berl). 2021;99(2):225\u201340.","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"445_CR113","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/jcb.20831","volume":"98","author":"RR Vogt","year":"2006","unstructured":"Vogt RR, Unda R, Yeh LC, Vidro EK, Lee JC, Tsin AT. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem. 2006;98(5):1196\u2013202.","journal-title":"J Cell Biochem"},{"issue":"10386","key":"445_CR114","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","volume":"401","author":"RH Guymer","year":"2023","unstructured":"Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023;401(10386):1459\u201372.","journal-title":"Lancet"},{"issue":"3","key":"445_CR115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257\u201393.","journal-title":"Surv Ophthalmol"},{"issue":"10153","key":"445_CR116","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147\u201359.","journal-title":"Lancet"},{"issue":"6","key":"445_CR117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000517520","volume":"244","author":"R Flores","year":"2021","unstructured":"Flores R, Carneiro \u00c2, Vieira M, Tenreiro S, Seabra MC. Age-related macular degeneration: pathophysiology, management, and future perspectives. Ophthalmologica. 2021;244(6):495\u2013511.","journal-title":"Ophthalmologica"},{"issue":"4","key":"445_CR118","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","volume":"27","author":"JS Penn","year":"2008","unstructured":"Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27(4):331\u201371.","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"445_CR119","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013;27(7):787\u201394.","journal-title":"Eye (Lond)"},{"issue":"10","key":"445_CR120","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/medicina60101647","volume":"60","author":"M Singh","year":"2024","unstructured":"Singh M, Negi R, Alka, Vinayagam R, Kang SG, Shukla P. Age-related macular degeneration (AMD): pathophysiology, drug targeting approaches, and recent developments in nanotherapeutics. Medicina (Kaunas). 2024;60(10):1647.","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"445_CR121","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1096\/fj.10-178350","volume":"25","author":"J Xu","year":"2011","unstructured":"Xu J, Zhu D, He S, Spee C, Ryan SJ, Hinton DR. Transcriptional regulation of bone morphogenetic protein 4 by tumor necrosis factor and its relationship with age-related macular degeneration. FASEB J. 2011;25(7):2221\u201333.","journal-title":"FASEB J"},{"issue":"2","key":"445_CR122","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm1709","volume":"14","author":"JG Hollyfield","year":"2008","unstructured":"Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14(2):194\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"445_CR123","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jcp.20304","volume":"204","author":"K Pardali","year":"2005","unstructured":"Pardali K, Kowanetz M, Heldin CH, Moustakas A. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1\/Cip1). J Cell Physiol. 2005;204(1):260\u201372.","journal-title":"J Cell Physiol"},{"issue":"14","key":"445_CR124","doi-asserted-by":"publisher","first-page":"9529","DOI":"10.1074\/jbc.M809393200","volume":"284","author":"D Zhu","year":"2009","unstructured":"Zhu D, Wu J, Spee C, Ryan SJ, Hinton DR. BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J Biol Chem. 2009;284(14):9529\u201339.","journal-title":"J Biol Chem"},{"issue":"2","key":"445_CR125","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10456-012-9254-4","volume":"15","author":"J Xu","year":"2012","unstructured":"Xu J, Zhu D, Sonoda S, He S, Spee C, Ryan SJ, et al. Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9. Angiogenesis. 2012;15(2):213\u201327.","journal-title":"Angiogenesis"},{"issue":"35","key":"445_CR126","doi-asserted-by":"publisher","first-page":"55957","DOI":"10.18632\/oncotarget.11182","volume":"7","author":"K Ntumba","year":"2016","unstructured":"Ntumba K, Akla N, Oh SP, Eichmann A, Larriv\u00e9e B. BMP9\/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration. Oncotarget. 2016;7(35):55957\u201369.","journal-title":"Oncotarget"},{"key":"445_CR127","first-page":"0710","volume":"2014","author":"D Steel","year":"2014","unstructured":"Steel D. Retinal detachment. BMJ Clin Evid. 2014;2014:0710.","journal-title":"BMJ Clin Evid"},{"issue":"3","key":"445_CR128","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/ijms26031025","volume":"26","author":"N Harju","year":"2025","unstructured":"Harju N, Kauppinen A, Loukovaara S. Fibrotic changes in rhegmatogenous retinal detachment. Int J Mol Sci. 2025;26(3):1025.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"445_CR129","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1096\/fj.201800858RR","volume":"33","author":"H Yao","year":"2019","unstructured":"Yao H, Ge T, Zhang Y, Li M, Yang S, Li H, et al. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro. FASEB J. 2019;33(3):3212\u201324.","journal-title":"FASEB J"},{"issue":"8","key":"445_CR130","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362(8):726\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"445_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40123-019-00226-9","volume":"9","author":"NM Hodgson","year":"2020","unstructured":"Hodgson NM, Rajaii F. Current understanding of the progression and management of thyroid associated orbitopathy: a systematic review. Ophthalmol Ther. 2020;9(1):21\u201333.","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"445_CR132","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.63.6.7","volume":"63","author":"BY Kim","year":"2022","unstructured":"Kim BY, Choi SH, Kim JY, Ko J, Yook JI, Kim HS, et al. Potential therapeutic role of bone morphogenic protein 7 (BMP7) in the pathogenesis of Graves\u2019 orbitopathy. Invest Ophthalmol Vis Sci. 2022;63(6):7.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"445_CR133","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","volume":"25","author":"S Kaye","year":"2006","unstructured":"Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res. 2006;25(4):355\u201380.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"445_CR134","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jtos.2018.10.002","volume":"17","author":"AM Lobo","year":"2019","unstructured":"Lobo AM, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: the host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf. 2019;17(1):40\u20139.","journal-title":"Ocul Surf"},{"issue":"1","key":"445_CR135","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neulet.2006.11.063","volume":"413","author":"MA Hamza","year":"2007","unstructured":"Hamza MA, Higgins DM, Ruyechan WT. Herpes simplex virus type-1 latency-associated transcript-induced immunoreactivity of substance P in trigeminal neurons is reversed by bone morphogenetic protein-7. Neurosci Lett. 2007;413(1):31\u20135.","journal-title":"Neurosci Lett"},{"issue":"2","key":"445_CR136","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/dvdy.20224","volume":"232","author":"AM Jensen","year":"2005","unstructured":"Jensen AM. Potential roles for BMP and Pax genes in the development of iris smooth muscle. Dev Dyn. 2005;232(2):385\u201392.","journal-title":"Dev Dyn"},{"issue":"4","key":"445_CR137","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1242\/bio.20149977","volume":"4","author":"KA Wong","year":"2015","unstructured":"Wong KA, Trembley M, Abd Wahab S, Viczian AS. Efficient retina formation requires suppression of both Activin and BMP signaling pathways in pluripotent cells. Biol Open. 2015;4(4):573\u201383.","journal-title":"Biol Open"},{"issue":"10","key":"445_CR138","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.tig.2017.08.001","volume":"33","author":"A Cvekl","year":"2017","unstructured":"Cvekl A, Zhang X. Signaling and gene regulatory networks in mammalian lens development. Trends Genet. 2017;33(10):677\u2013702.","journal-title":"Trends Genet"},{"issue":"1","key":"445_CR139","doi-asserted-by":"publisher","first-page":"C282","DOI":"10.1152\/ajpcell.00306.2005","volume":"290","author":"S Saika","year":"2006","unstructured":"Saika S, Ikeda K, Yamanaka O, Flanders KC, Ohnishi Y, Nakajima Y, et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol. 2006;290(1):C282\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"key":"445_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111167","volume":"194","author":"L Xu","year":"2020","unstructured":"Xu L, Zhang Y, Wang S, Hu H, Zhong S, He S, et al. Thermoresponsive gel for sustained release of BMP4 to inhibit corneal neovascularization. Colloids Surf B Biointerfaces. 2020;194:111167.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"445_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100944","volume":"24","author":"W Nan","year":"2024","unstructured":"Nan W, Shen S, Yang Y, Wu M, He Y, Zhang R, et al. Bone morphogenetic protein 4 thermosensitive hydrogel inhibits corneal neovascularization by repairing corneal epithelial apical junctional complexes. Mater Today Bio. 2024;24:100944.","journal-title":"Mater Today Bio"},{"issue":"4","key":"445_CR142","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s13577-020-00380-4","volume":"33","author":"E Katsuta","year":"2020","unstructured":"Katsuta E, Rashid OM, Takabe K. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models. Hum Cell. 2020;33(4):930\u20137.","journal-title":"Hum Cell"},{"issue":"10","key":"445_CR143","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/cells8101130","volume":"8","author":"F Dituri","year":"2019","unstructured":"Dituri F, Cossu C, Mancarella S, Giannelli G. The interactivity between TGF\u03b2 and BMP signaling in organogenesis, fibrosis, and cancer. Cells. 2019;8(10):1130.","journal-title":"Cells"},{"key":"445_CR144","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2106\/00004623-200300003-00014","volume":"85","author":"TA Einhorn","year":"2003","unstructured":"Einhorn TA. Clinical applications of recombinant human BMPs: early experience and future development. J Bone Joint Surg Am. 2003;85(Suppl 3):82\u20138.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"445_CR145","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-409X(00)00078-8","volume":"43","author":"CA Kirker-Head","year":"2000","unstructured":"Kirker-Head CA. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev. 2000;43(1):65\u201392.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-025-00445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-025-00445-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-025-00445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:28:40Z","timestamp":1757280520000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-025-00445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s40662-025-00445-1","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}